Literature DB >> 17022038

Degeneration of neuronal cell bodies following axonal injury in Wld(S) mice.

Ai Ling Wang1, Ming Yuan, Arthur H Neufeld.   

Abstract

The phenotype of Wld(S) ("slow Wallerian degeneration") mice demonstrates prolonged survival of injured axons. However, whether the Wld(S) mutation delays degeneration of the neuronal cell body following axonal injury is unclear. We used a retrograde model of axonal transport failure in Wld(S) mice to test whether the mutant Wld(S) protein has any beneficial effect on the neuronal cell body. Retrograde axonal transport was physically blocked by optic nerve crush and confirmed by the absence of Fluoro-Gold labeling in wild-type and in Wld(S) mice. After this axonal injury, there was marked protection of axonal degeneration in the Wld(S) phenotype, as confirmed by immunohistochemistry and electron microscopy. However, the Wld(S) protein, localized in the nucleus of retinal ganglion cells, did not prevent or delay degeneration of the retinal ganglion cell body, confirmed by TUNEL staining and Fluoro-Gold labeling. These results imply that, after axonal injury, Wallerian degeneration of axons and degeneration of the neuronal cell body have different mechanisms, which are autonomous and independent of each other. Although the Wld(S) phenotype can be used to demonstrate stable enucleate axons, the mutation is unlikely to protect neurons in neurodegenerative diseases in which there is failure of retrograde transport.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17022038     DOI: 10.1002/jnr.21075

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  9 in total

1.  Imaging of rat optic nerve axons in vivo.

Authors:  Jan C Koch; Johanna Knöferle; Lars Tönges; Uwe Michel; Mathias Bähr; Paul Lingor
Journal:  Nat Protoc       Date:  2011-11-03       Impact factor: 13.491

2.  Dose-dependent treatment of optic nerve crush by exogenous systemic mutant erythropoietin.

Authors:  Timothy A Sullivan; Eldon E Geisert; Justin P Templeton; Tonia S Rex
Journal:  Exp Eye Res       Date:  2012-01-27       Impact factor: 3.467

3.  Nicotinamide mononucleotide adenylyl transferase 1 protects against acute neurodegeneration in developing CNS by inhibiting excitotoxic-necrotic cell death.

Authors:  Philip B Verghese; Yo Sasaki; Donghan Yang; Floy Stewart; Fatima Sabar; Mary Beth Finn; Christine M Wroge; Steven Mennerick; Jeffrey J Neil; Jeffrey Milbrandt; David M Holtzman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-04       Impact factor: 11.205

4.  Protection of mouse retinal ganglion cell axons and soma from glaucomatous and ischemic injury by cytoplasmic overexpression of Nmnat1.

Authors:  Yanli Zhu; Lihong Zhang; Yo Sasaki; Jeffrey Milbrandt; Jeffrey M Gidday
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-02       Impact factor: 4.799

Review 5.  NAD and axon degeneration: from the Wlds gene to neurochemistry.

Authors:  Jing Wang; Zhigang He
Journal:  Cell Adh Migr       Date:  2009-01-25       Impact factor: 3.405

6.  Effects of targeted muscle reinnervation on spinal cord motor neurons in rats following tibial nerve transection.

Authors:  Wei Lu; Jian-Ping Li; Zhen-Dong Jiang; Lin Yang; Xue-Zheng Liu
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

7.  Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene.

Authors:  Thomas M Wishart; Janet M Paterson; Duncan M Short; Sara Meredith; Kevin A Robertson; Calum Sutherland; Michael A Cousin; Mayank B Dutia; Thomas H Gillingwater
Journal:  Mol Cell Proteomics       Date:  2007-04-29       Impact factor: 5.911

8.  Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wlds).

Authors:  Thomas M Wishart; Helen N Pemberton; Sally R James; Chris J McCabe; Thomas H Gillingwater
Journal:  Genome Biol       Date:  2008-06-20       Impact factor: 13.583

9.  JUN is important for ocular hypertension-induced retinal ganglion cell degeneration.

Authors:  Stephanie B Syc-Mazurek; Kimberly A Fernandes; Richard T Libby
Journal:  Cell Death Dis       Date:  2017-07-20       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.